In the device tax battle, one industry group didn't devote more lobbying cash

AdvaMed steadily ramped up its lobbying spending through 2012 and into 2013 as a push to repeal the 2.3% medical device tax heated up. But that's not the case for the Medical Device Manufacturers Association, which represents a lot of smaller device companies. Roll Call reported that AdvaMed went through nearly $643,000 during the 2013 second quarter, capping a steady increase from the 2012 third quarter, when lobbying-related spending reached just under $267,500. (2013 third quarter numbers aren't out yet.) The Medical Device Manufacturers Association, on the other hand, said it committed $90,000 to lobbying efforts during the 2013 third quarter, according to the story, a quarterly spending amount that has remained unchanged since early 2009. The industry continues to push for a repeal of the tax during the government shutdown. Story

Suggested Articles

The former CEO of the molecular testing company Foundation Medicine, Troy Cox, has been named chairman of the Swiss big data firm Sophia Genetics.

Researchers at MIT used a machine-learning algorithm to uncover the potent antibiotic properties hiding within an old small-molecule candidate.

The randomized, blinded study showed statistically significant improvements in assessments of inattention and brain activity.